Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/17/2004 | US20040115775 Homogeneity and secretion of recombinant proteins in mammalian systems |
06/17/2004 | US20040115773 Serpin in bifidobacteria |
06/17/2004 | US20040115768 including culturing the cells at a temperature below 37 degrees C in a solution of mannose, galactose, or fructose; solution may be serum-free; genetic engineering |
06/17/2004 | US20040115762 Comprises nucleotide sequences coding enzymatic polypeptide associated biosynthesis of nystatin and treatment of bacterial, fungal and parasitic infections; immunosuppressant; antitumor agents |
06/17/2004 | US20040115743 Test kit for intracellular introduction of protein and/or peptide and method of intracellular introduction |
06/17/2004 | US20040115704 Identifying, evaluating and characterizing activity of transcriptional control elements using expression vectors and/or reporter vectors providing kinetics of protein expression; drug screening and discovery |
06/17/2004 | US20040115700 Comprises nucleotide sequences coding transcriptional splice variants of hippocampal and mammary gland negative regulatory protein for use in diagnosis and treatment of alzheimer's disease |
06/17/2004 | US20040115697 Detecting tumors disorders via identifying centrosomal aberrations in microtubule organizing center of cell |
06/17/2004 | US20040115695 Methods for generating enhanced antibody producing cell lines with improved growth characteristics |
06/17/2004 | US20040115667 Dna-sequences, which code for an apoptosis signal transduction protein |
06/17/2004 | US20040115666 Method for identifying compounds modulating reverse cholesterol transport |
06/17/2004 | US20040115656 Androgen receptor down-regulatory-associated proteins(ARDAPs) for use in reduction of transactivation activity of androgen receptors and treatment of tumors; gene expression inhibition and anticarcinogenic agents |
06/17/2004 | US20040115627 Genetically engineered cells comprising regulatory elements for use as tools in identifying compounds that alter protein expression: high throughput assay |
06/17/2004 | US20040115306 Prolyl-specific endoprotease is added to the beverage |
06/17/2004 | US20040115238 Muscle-polymer constructs for bone tissue engineering |
06/17/2004 | US20040115224 Preparation and administration of hybrid cell vaccines for the prevention of cancer |
06/17/2004 | US20040115220 Vaccine |
06/17/2004 | US20040115216 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
06/17/2004 | US20040115202 monospecific antibody which specifically binds an epitope of a mammalian DPPIV (dipeptidyl peptidase IV, also known as CD26). |
06/17/2004 | US20040115199 Method for down-regulating osteoprotegerin ligand activity |
06/17/2004 | US20040115184 Methods and compositions for modifying apolipoprotein b mrna editing |
06/17/2004 | US20040115176 Fibrin-based tissue-engineered vasculature |
06/17/2004 | US20040115175 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
06/17/2004 | US20040115173 Method of treating inflammation, particularly diabetes |
06/17/2004 | DE10255508A1 Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen A method for culturing cells for the production of substances |
06/17/2004 | CA2706873A1 Modified neomycin-phosphotransferase gene that increases expression rates of co-integrated gene and uses thereof |
06/17/2004 | CA2508223A1 Germ-responsive promoter |
06/17/2004 | CA2507395A1 Method for culturing neural stem cells using hepatocyte growth factor |
06/17/2004 | CA2503973A1 Material compositions and related systems and methods for treating cardiac conditions |
06/17/2004 | CA2485341A1 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
06/17/2004 | CA2469724A1 Mutant glycoproteins |
06/17/2004 | CA2453387A1 Compositions and methods related to nitrotyrosine-containing compounds as antigenic agents |
06/16/2004 | EP1428889A1 Method for monitoring the transition of a cell from one state into another |
06/16/2004 | EP1428886A1 Improved retroviral vectors for gene therapy |
06/16/2004 | EP1428883A1 Megakaryocyte stimulating factors |
06/16/2004 | EP1428881A1 Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same |
06/16/2004 | EP1428880A1 Kidney-specific urate transporter and gene thereof |
06/16/2004 | EP1428872A2 Tolerance-inducing thymus-bone marrow composite tissue construct and organ |
06/16/2004 | EP1428871A1 Cultured cell construct containing spheroids of cultured animal cells and utilization thereof |
06/16/2004 | EP1428834A1 Ligands for flt3 receptors |
06/16/2004 | EP1427856A2 Fusion proteins useful for detecting analytes |
06/16/2004 | EP1427841A2 Nucleic acid-associated proteins |
06/16/2004 | EP1427838A1 Plant enzymes for bioconversion |
06/16/2004 | EP1427836A2 Pseudotyped retroviral vector system |
06/16/2004 | EP1427830A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
06/16/2004 | EP1427828A2 Random integration of a polynucleotide after in vivo linearization |
06/16/2004 | EP1427827A2 Synthetic hcv envelope proteins and their use for vaccination |
06/16/2004 | EP1427825A2 Cdna encoding the human alpha2 delta4 calcium channel subunit |
06/16/2004 | EP1427822A2 Nucleic acid for cloning vector |
06/16/2004 | EP1427819A2 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
06/16/2004 | EP1427817A1 Multiplication of viruses in a cell culture |
06/16/2004 | EP1427815A2 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture |
06/16/2004 | EP1427814A1 Pancreatic small cells and uses thereof |
06/16/2004 | EP1427812A2 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery |
06/16/2004 | EP1427811A1 Erythrocytic cells and method for preserving cells |
06/16/2004 | EP1427810A2 Method and quantification assay for determining c-kit/scf/pakt status |
06/16/2004 | EP1427806A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
06/16/2004 | EP1427758A2 Compositions and methods of treating diabetes |
06/16/2004 | EP1427754A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor |
06/16/2004 | EP1427753A2 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications |
06/16/2004 | EP1427750A1 Modified transferrin fusion proteins |
06/16/2004 | EP1427742A1 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof |
06/16/2004 | EP1427528A2 Plate and method for high throughput screening |
06/16/2004 | EP1427462A1 Method for inducing selectively suppressed immune response |
06/16/2004 | EP1427445A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules |
06/16/2004 | EP1427405A2 Inflammation-inhibiting compounds |
06/16/2004 | EP1427399A2 Retinoid receptor pan-antagonists for stimulating chondrogenesis |
06/16/2004 | EP1427279A1 Preservation of non embryonic cells from non hematopoietic tissues |
06/16/2004 | EP1301589A4 Culturing pancreatic stem cells having a specified, intermediate stage of development |
06/16/2004 | EP1152767B1 Method for producing anti-tumor th1 cells |
06/16/2004 | EP1127106A4 Glufosinate tolerant rice |
06/16/2004 | EP1009844B1 IMPROVED $i(AGROBACTERIUM)-MEDIATED TRANSFORMATION OF PLANTS |
06/16/2004 | EP1005540B1 Ikk-beta proteins, nucleic acids and methods |
06/16/2004 | EP0892850A4 Immortalized hepatocytes |
06/16/2004 | EP0847530B1 QUANTITATION OF p97 TO DIAGNOSE AND MONITOR ALZHEIMER'S DISEASE |
06/16/2004 | EP0791078B1 Methods for drug screening |
06/16/2004 | EP0787299B1 Receptor for a bacillus thuringiensis toxin |
06/16/2004 | EP0672133B1 TNF-alpha RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-alpha RIBOZYMES |
06/16/2004 | CN1505679A Alkaline protease variants, and detergents and cleaning agents containing the same |
06/16/2004 | CN1505526A Compositions and methods for wt1 specific immunotherapy |
06/16/2004 | CN1504752A Vaughan Tristan J. |
06/16/2004 | CN1504477A Chicken polydactyly functional gene and uses thereof |
06/16/2004 | CN1153833C Poplar chloroplast site-specific transformation method and DNA sequence for said method |
06/16/2004 | CN1153792C Biological material embedded in hydrogels, process for embedding thereof, and its use as artificial seed |
06/16/2004 | CN1153589C Treatment of infertility and enhancement of fertilization capacity in mammalian males |
06/15/2004 | US6750378 Maize H3C4 promoter combined with the first intron of rice actin, chimeric gene comprising it and transformed plant |
06/15/2004 | US6750327 Compositions and method for determining the presence of human PTTG peptide in a sample |
06/15/2004 | US6750326 Method for separating cells using immunorosettes |
06/15/2004 | US6750206 Recombinant nucleic acid vector comprising a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
06/15/2004 | US6750196 Methods of treating disorders of the eye |
06/15/2004 | US6750044 For producing pharmaceutically active materials having therapeutic and pharmacologic properties that differ from native vegf protein |
06/15/2004 | US6750041 Homologous recombination antibody expression system for murine cells |
06/15/2004 | US6750034 Useful as therapeutic agents for cancer, skin disorders, neuropathic pain, inflammatory, or coagulation diathesis/thrombosis; may also be useful for laundry detergents and skin care products; derived from humans |
06/15/2004 | US6750021 Subtle mitochondrial mutations as tumor markers |
06/15/2004 | US6750012 For identifying compounds that do not induce motor side effects |
06/15/2004 | US6750009 Multiple viral replicon culture systems |
06/15/2004 | US6749858 Nucleotide sequences coding polypeptide for use in the prevention of streptoccocus infection |
06/15/2004 | US6749857 Recombinant dimeric envelope vaccine against flaviviral infection |
06/10/2004 | WO2004048922A2 Bead-based detection of ligand-gpcr-g protein complexes |
06/10/2004 | WO2004048601A2 Modulation of b7h expression |